Active folate and methyl B12 function as interdependent co-factors, essential for driving the methylation cycle and regulating homocysteine levels
Wu, Z., Zhao, L., Chen, X., Cheng, X
GLP-1 receptor agonists effectively support weight loss, but gastrointestinal side effects affect up to 70% of users during early treatment phases
3.2 Diabetic retinopathy The number of trials and research examining the relationship between GLP-1RAs and DR is growing rapidly in recent years
From Wikipedia, the free encyclopedia Pramlintide (trade name Symlin ) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)